Cargando…
Cutaneous Leishmaniasis: Update on Vaccine Development
Leishmaniasis is an important disease mediated by the protozoan parasite Leishmania via the bite of the female sandfly insect vector. Leishmaniasis is endemic in the tropical and subtropical regions. The most common form of the disease is cutaneous leishmaniasis, which affects more than 10 million p...
Autores principales: | Whyte, Davian C, Zufferey, Rachel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921938/ https://www.ncbi.nlm.nih.gov/pubmed/29708235 |
Ejemplares similares
-
UPDATE IN THE TREATMENT OF CUTANEOUS LEISHMANIASIS
por: Al-Natour, Sahar H.
Publicado: (2009) -
Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management Developments
por: de Vries, Henry J. C., et al.
Publicado: (2022) -
Updated estimation of cutaneous leishmaniasis incubation period in French Guiana
por: Blaizot, Romain, et al.
Publicado: (2023) -
Protective Immunity and Vaccination Against Cutaneous Leishmaniasis
por: Okwor, Ifeoma, et al.
Publicado: (2012) -
Cutaneous Leishmaniasis Vaccination: A Matter of Quality
por: De Luca, Paula Mello, et al.
Publicado: (2016)